Teligent Inc. (NASDAQ:TLGT) will be issuing its quarterly earnings data on Thursday, October 20th.
Teligent (NASDAQ:TLGT) last released its earnings results on Thursday, July 28th. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.04. Teligent had a negative return on equity of 1.49% and a negative net margin of 22.81%. The firm had revenue of $17.14 million for the quarter, compared to analyst estimates of $16.03 million. During the same quarter in the prior year, the firm posted ($0.05) earnings per share. The company’s quarterly revenue was up 92.8% on a year-over-year basis. On average, analysts expect Teligent to post $0.01 EPS for the current fiscal year and $0.21 EPS for the next fiscal year.
Teligent Inc. (NASDAQ:TLGT) opened at 7.08 on Tuesday. The firm’s market cap is $375.91 million. The firm has a 50-day moving average price of $7.63 and a 200 day moving average price of $6.93. Teligent Inc. has a 1-year low of $4.46 and a 1-year high of $9.18.
Several equities analysts have weighed in on the company. Zacks Investment Research raised Teligent from a “hold” rating to a “buy” rating and set a $8.75 price objective for the company in a report on Wednesday, October 12th. JMP Securities began coverage on Teligent in a research note on Wednesday, June 29th. They issued a “hold” rating on the stock. TheStreet upgraded Teligent from a “sell” rating to a “hold” rating in a research note on Thursday, June 23rd. Finally, Raymond James Financial Inc. began coverage on Teligent in a research note on Wednesday, June 22nd. They issued a “strong-buy” rating and a $11.00 price target on the stock. Four investment analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $9.25.
A number of large investors have recently modified their holdings of the company. California Public Employees Retirement System raised its stake in shares of Teligent by 0.8% in the second quarter. California Public Employees Retirement System now owns 25,600 shares of the company’s stock worth $183,000 after buying an additional 200 shares in the last quarter. Alliancebernstein L.P. raised its stake in shares of Teligent by 4.9% in the second quarter. Alliancebernstein L.P. now owns 36,200 shares of the company’s stock worth $258,000 after buying an additional 1,700 shares in the last quarter. ProShare Advisors LLC raised its stake in shares of Teligent by 0.8% in the second quarter. ProShare Advisors LLC now owns 44,563 shares of the company’s stock worth $318,000 after buying an additional 362 shares in the last quarter. Teachers Advisors Inc. raised its stake in shares of Teligent by 7.5% in the second quarter. Teachers Advisors Inc. now owns 64,806 shares of the company’s stock worth $463,000 after buying an additional 4,507 shares in the last quarter. Finally, Menta Capital LLC raised its stake in shares of Teligent by 65.5% in the second quarter. Menta Capital LLC now owns 112,085 shares of the company’s stock worth $800,000 after buying an additional 44,380 shares in the last quarter. Institutional investors and hedge funds own 69.64% of the company’s stock.
Teligent Company Profile
Teligent, Inc, formerly IGI Laboratories, Inc, is a specialty generic pharmaceutical company. The Company markets and sells generic injectable pharmaceutical products under its own label in the United States and Canada. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries.
Receive News & Ratings for Teligent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.